Edwards Lifesciences Corporation Stock
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
04:00:03 2026-09-10 pm EDT
|
5-day change | 1st Jan Change | ||
| 86.77 USD | +0.68% |
|
-3.35% | +1.78% |
| Market Cap | 50.01B 43.01B 40.58B 36.97B 69.11B 4,782B 69.74B 483B 186B 2,425B 188B 184B 7,704B | P/E 2026 * |
34.3x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 46.38B 39.89B 37.64B 34.29B 64.09B 4,435B 64.68B 448B 173B 2,249B 174B 170B 7,144B | EV / Sales 2026 * |
6.86x | EV / Sales 2027 * | 6.03x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Tradegate
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Edwards Lifesciences Corporation
| 1 day | +0.68% | ||
| 1 week | -3.35% | ||
| Current month | -4.39% | ||
| 1 month | -5.72% | ||
| 3 months | +0.92% | ||
| 6 months | +1.15% | ||
| Current year | +1.78% |
| 1 week | 85 |  | 89.1 |
| 1 month | 85 | | 93.75 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 2026-05-28 |
| Chief Tech/Sci/R&D Officer | 51 | 2025-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Sell | Controller/Auditor | -544 | 0.0001% | ||
| 8/28/26 | Sell | Executive/Senior Manager | -2,644 | 0.0005% | ||
| 8/26/26 | Sell | Executive/Senior Manager | -1,240 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | -3.35% | +10.85% | +17.15% | 50.01B | |
| -0.41% | -2.47% | +26.57% | +16.38% | 223B | |
| -2.11% | -4.98% | +4.12% | -19.26% | 141B | |
| +2.04% | -2.53% | -19.89% | +20.87% | 127B | |
| -4.14% | -8.20% | -59.04% | -19.99% | 62.46B | |
| -0.70% | -1.00% | -20.42% | -13.99% | 49.73B | |
| -1.13% | -4.57% | +15.31% | +25.55% | 40.35B | |
| -0.78% | -2.88% | +37.06% | +52.38% | 39.46B | |
| -0.17% | -4.19% | -18.82% | +48.42% | 31.41B | |
| -1.82% | -9.20% | +110.78% | +27.10% | 30.39B | |
| Average | -0.63% | -3.72% | +8.65% | +15.46% | 79.52B | |
| Weighted average by Cap. | -0.63% | -3.36% | +5.87% | +10.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 5.81B 5.48B 5B 9.34B 646B 9.43B 65.32B 25.14B 328B 25.38B 24.83B 1,041B | 7.43B 6.39B 6.03B 5.49B 10.27B 710B 10.36B 71.79B 27.63B 360B 27.9B 27.29B 1,144B |
| Net income | 1.44B 1.23B 1.16B 1.06B 1.98B 137B 2B 13.87B 5.34B 69.6B 5.39B 5.27B 221B | 1.9B 1.63B 1.54B 1.4B 2.62B 181B 2.64B 18.33B 7.05B 91.98B 7.12B 6.97B 292B |
| Net Debt | -3.63B -3.12B -2.95B -2.68B -5.02B -347B -5.06B -35.09B -13.5B -176B -13.63B -13.34B -559B | -5.19B -4.47B -4.22B -3.84B -7.18B -497B -7.24B -50.2B -19.32B -252B -19.51B -19.08B -800B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | $86.77 | +0.68% | 2,310,829 |
| 26-09-09 | $86.18 | -0.62% | 2,736,837 |
| 26-09-08 | $86.72 | -3.54% | 3,583,538 |
| 26-09-04 | $89.90 | +0.13% | 2,635,295 |
| 26-09-03 | $89.78 | -1.15% | 1,844,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
